People on the Move Archives - Page 100 of 126

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

May 13, 2025

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

May 7, 2025

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

May 12, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

People on the Move

Oklo Names Nuclear Industry Veteran Pat Schweiger as Chief Technology Officer

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

Ted Myles Named CEO of Cellarity as Company Prepares for First Clinical Trial

Adtalem Appoints Megan Noel as Chief Corporate Affairs Officer

Aera Therapeutics Names Paul Conrad as Chief Business and Financial Officer

Most Read

Large Study Confirms Safety and Life-Saving Benefits of Contrast-Enhanced Ultrasound

Faeth Therapeutics Publishes Preclinical Data Supporting Drug-Diet Combo for Metabolism-Driven Cancers

GSK Acquires Phase III-Ready Efimosfermin to Advance Liver Disease Treatment Portfolio

CapeStart Unveils Major Upgrade to MadeAi Platform, Streamlining Life Sciences Research with Generative AI

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

FDA Advisory Committee to Review UroGen’s UGN-102 Bladder Cancer Treatment on May 21

Dr. Ellen Marmur Joins MedSpa Partners, Strengthening Northeast Presence and Industry Leadership

POPULAR CATEGORY

ABOUT US

FOLLOW US